In conclusion, our study revealed that TROAP could promote malignant phenotype of glioma cells in vitro, at least in part, activating Wnt/β‐Catenin signaling pathway, thus proving the role of TROAP and underlying molecular mechanism of TROAP in gliomagenesis for the first time. This evidence concerns the gene TROAP and central nervous system cancer.